Andrew Rubinstein
Fondatore presso Oberland Capital Management LLC
Profilo
Andrew Rubinstein is the founder of Oberland Capital Management LLC, which was founded in 2013.
He is currently the Managing Partner at Oberland Capital Management LLC.
He is also currently the Director at Primmune Therapeutics, Inc. Mr. Rubinstein previously held the position of Chief Executive Officer at Microban International Ltd.
He also worked as a Principal at Paul Capital Partners LP from 2007 to 2010.
Additionally, he has experience as an Investment Banker at Merrill Lynch & Co., Inc. Mr. Rubinstein completed his undergraduate and graduate degrees at the University of Pennsylvania.
He also holds a graduate degree, specifically an MBA, from New York University.
Posizioni attive di Andrew Rubinstein
| Società | Posizione | Inizio |
|---|---|---|
Oberland Capital Management LLC
 Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Fondatore | 01/01/2013 |
Primmune Therapeutics, Inc.
 Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Andrew Rubinstein
| Società | Posizione | Fine |
|---|---|---|
Microban International Ltd.
 Microban International Ltd. Chemicals: Major DiversifiedProcess Industries Microban International Ltd. provides built-in antimicrobial product protection and antifungal solutions. The firm serves consumer, industrial and medical product to avoid the growth of microbes, such as bacteria, mold and mildew that can cause stains, odors and deterioration of a product. It has locations in North America, Latin America, Europe and Asia. The company was founded in 1984 and is headquartered in Huntersville, NC. | Presidente | - |
| Merrill Lynch & Co., Inc. | Corporate Officer/Principal | - |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investitore di Private Equity | - |
Formazione di Andrew Rubinstein
| University of Pennsylvania | Graduate Degree |
| New York University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Paul Capital Partners LP
Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Finance |
Microban International Ltd.
Microban International Ltd. Chemicals: Major DiversifiedProcess Industries Microban International Ltd. provides built-in antimicrobial product protection and antifungal solutions. The firm serves consumer, industrial and medical product to avoid the growth of microbes, such as bacteria, mold and mildew that can cause stains, odors and deterioration of a product. It has locations in North America, Latin America, Europe and Asia. The company was founded in 1984 and is headquartered in Huntersville, NC. | Process Industries |
| Merrill Lynch & Co., Inc. | Finance |
Oberland Capital Management LLC
Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Finance |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Commercial Services |
- Borsa valori
- Insiders
- Andrew Rubinstein
